5 Major Mistakes to Avoid During Medicare Open Enrollment

Medicare open enrollment runs through Dec. 7, giving enrollees an opportunity to change coverage for 2027. The article advises reviewing plan changes, total out-of-pocket costs, anticipated care needs, and provider networks early rather than waiting until the deadline.

Analysis

This is a weak market signal, not evidence of a change in Medicare enrollment behavior. The investable mechanism is retention and mix: if beneficiaries respond to higher total out-of-pocket costs, narrower networks, or drug formulary changes by switching plans, Medicare Advantage and Part D insurers could face higher acquisition/retention costs and less predictable membership. Providers may also see patient churn where network participation differs. But annual plan changes are already embedded in insurer bids and benefits; an educational article alone says nothing about actual switching, pricing, or margins.

Over the next 1–3 months, watch CMS enrollment data and company disclosures for membership changes, benefit adjustments, and indications that members are moving toward lower-cost plans. For UnitedHealth, Humana, CVS Health, Elevance Health, and Centene, the key distinction is whether enrollment gains preserve risk-adjusted economics rather than simply add price-sensitive members. Over 6–18 months, sustained benefit reductions or network disruption could affect retention and provider access, but utilization, risk adjustment, and CMS payment policy may matter more than shopping guidance.

Contrarian view: heightened attention to plan comparison may not produce meaningful switching; enrollment friction, provider relationships, and medication continuity can outweigh premium differences. No trade is warranted from this item alone. The thesis would strengthen with disclosed elevated disenrollment, weaker MA membership guidance, or rising medical-cost ratios; it would be weakened by stable retention and margins despite benefit changes.

Key Decisions for Investors

• No immediate position change based on this article; treat it as background rather than a new earnings catalyst.
• Monitor upcoming CMS enrollment data and insurer commentary for retention, plan mix, and membership acquisition costs, especially at UnitedHealth, Humana, CVS Health, Elevance Health, and Centene.
• Flag for reassessment if insurers report weaker Medicare Advantage retention alongside rising medical-cost ratios or reduced membership guidance; stable retention and margins would falsify the concern.